Skip to main content
logo
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.01
+0.01 (0.21%)
Sep 14, 2026, 4:00 PM EDT - Market closed

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
726783429346384388294411442375389436343467351389530415643496-
Market Cap Growth (YoY)
81.46%101.76%45.82%-15.71%-13.14%3.63%-24.26%-5.92%29.00%-19.77%10.78%12.22%-35.41%12.59%-45.43%-21.59%-----
Enterprise Value
419685302202225279162255274191182308201314183298409282495631-
Last Close Price
7.007.106.695.456.186.265.868.228.917.567.858.868.9712.359.2810.5018.1214.1722.0016.98-

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PB Ratio
2.302.484.002.532.452.222.302.702.531.961.861.932.262.811.951.994.613.214.563.26-
P/TBV Ratio
2.312.484.002.532.452.222.302.702.531.961.861.932.262.811.951.994.613.214.563.26-

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.050.050.160.130.110.100.140.120.110.100.090.090.130.120.110.110.180.010.010.010.01
Net Debt / Equity Ratio
-0.97-0.97-0.91-0.93-0.92-0.91-0.86-0.87-0.89-0.88-0.88-0.91-0.85-0.85-0.85-0.86-0.79-0.94-0.94-0.97-0.96
Net Debt / EBITDA Ratio
2.242.240.831.141.281.481.081.391.691.892.122.471.681.962.332.841.702.633.214.302.91
Net Debt / FCF Ratio
2.972.971.071.491.621.891.371.632.082.262.533.201.982.342.713.021.802.502.944.293.16
Quick Ratio
16.6516.656.877.858.6011.9410.5210.1311.8517.7721.0018.3013.6818.2121.4018.0611.1921.0126.6420.2714.03
Current Ratio
16.8216.827.098.159.0412.3911.0610.7712.4718.5421.9718.7614.1318.6922.1018.8111.6321.9727.9020.9014.31
Return on Equity (ROE)
-86.41%-110.37%-69.65%-63.10%-71.43%-78.54%-63.27%-45.98%-40.65%-36.27%-46.89%-46.55%-42.23%-37.18%-42.64%-52.10%-39.88%-35.00%-39.34%-39.98%
Return on Assets (ROA)
-49.47%-56.77%-37.89%-35.38%-39.76%-42.96%-35.85%-27.42%-25.11%-22.76%-28.50%-27.50%-25.42%-22.61%-23.99%-28.86%-24.55%-20.90%-23.19%-23.49%
Return on Capital Employed (ROCE)
-42.00%-42.00%-98.10%-74.70%-66.20%-57.30%-71.80%-57.40%-48.80%-43.50%-39.00%-35.00%-46.10%-39.90%-33.80%-28.20%-40.80%-36.50%-29.80%-23.10%-33.60%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
-18.02%-16.73%-26.19%-30.68%-27.73%-26.12%-32.17%-21.17%-18.83%-21.54%-20.24%-17.51%-20.67%-14.61%-18.07%-15.11%-10.15%-11.28%-6.56%-7.11%-
FCF Yield
-14.22%-13.20%-21.35%-24.61%-23.13%-21.70%-27.20%-19.74%-16.86%-19.86%-18.68%-14.79%-19.04%-12.97%-16.08%-14.32%-9.47%-11.74%-7.02%-6.96%-
Buyback Yield / Dilution
-42.27%-63.51%-34.56%-34.37%-32.77%-17.09%-1.36%-11.84%-30.06%-30.89%-30.88%-39.49%-30.44%-29.41%-29.34%-65.34%-6531.26%-6586.60%-7195.20%-4986.58%-17.18%
SEC Filings: 10-K · 10-Q